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The rhizosphere-colonizing bacterium Pseudomonas chlororaphis 30-84 is an effective biological control agent against take-all
disease of wheat. In this study, we characterize a small-colony variant (SCV) isolated from a P. chlororaphis 30-84 biofilm. The
SCV exhibited pleiotropic phenotypes, including small cell size, slow growth andmotility, low levels of phenazine production,
and increased biofilm formation and resistance to antimicrobials. To better understand the genetic alterations underlying these
phenotypes, RNA and whole-genome sequencing analyses were conducted comparing an SCV to the wild-type strain. Of the ge-
nome’s 5,971 genes, transcriptomic profiling indicated that 1,098 (18.4%) have undergone substantial reprograming of gene ex-
pression in the SCV.Whole-genome sequence analysis revealed multiple alterations in the SCV, including mutations in yfiR (cy-
clic-di-GMP production), fusA (elongation factor), and cyoE (heme synthesis) and a 70-kb deletion. Genetic analysis revealed
that the yfiR locus plays a major role in controlling SCV phenotypes, including colony size, growth, motility, and biofilm forma-
tion. Moreover, a point mutation in the fusA gene contributed to kanamycin resistance. Interestingly, the SCV can partially
switch back to wild-type morphologies under specific conditions. Our data also support the idea that phenotypic switching in P.
chlororaphis is not due to simple genetic reversions but may involve multiple secondary mutations. The emergence of these
highly adherent and antibiotic-resistant SCVs within the biofilmmight play key roles in P. chlororaphis natural persistence.
Pseudomonas chlororaphis 30-84 is a rhizosphere bacterium thatis effective against take-all disease of wheat, which is caused by
the soilborne fungal pathogen Gaeumannomyces graminis var.
tritici. P. chlororaphis 30-84 produces several secondary metabo-
lites, including phenazines, that contribute to pathogen inhibition
and persistence in the rhizosphere (1). Previous studies revealed
additional critical roles of phenazines. For instance, phenazines
are involved in bacterial biofilm formation (2). Phenazines also
serve as signals and have been shown to regulate the expression of
more than 50 genes in the opportunistic pathogen Pseudomonas
aeruginosa and 200 genes in P. chlororaphis 30-84, respectively (3;
D. Wang and E. A. Pierson, unpublished data). Additionally,
phenazines have been shown to induce plant defense pathways
and play a role in electron shuttling and iron chelation (4–6).
Many bacteria establish long-term populations on their hosts
or within specific environments. One strategy for bacterial persis-
tence is the formation of biofilms, bacterial aggregates embedded
in a self-produced matrix (7). Compared to free-living cells, the
cells living in the biofilm microenvironment may be exposed to
smaller amounts of free iron, oxygen, and nutrients (7, 8). To cope
with these limiting factors, genes involved in stress response, iron
uptake, low oxygen growth, and antibiotic resistance are highly
induced under biofilm conditions (7, 8).
Many Pseudomonas species undergo phenotypic diversifica-
tion while adapting to the biofilm environment (9, 10). Small-
colony variants (SCVs) are slow-growing (lowmetabolic activity)
isolates commonly characterized by several phenotypes, including
chromatin aggregation, high adherence, and enhanced antimicro-
bial resistance (11). SCVs have been isolated in a wide array of
bacterial species, including Pseudomonas aeruginosa (11–13) and
Pseudomonas fluorescens (14). The occurrence of SCVs generally
correlates with prolonged persistence and increased antibiotic re-
sistance. A recent analysis of the spatial distribution of P. fluore-
scens SCVs in mixed-culture biofilms with the wild type (WT)
reveals that SCVs demonstrate a significant growth advantage
over the WT in the biofilm environment (14). The variant strains
displaced the WT across the entire biofilm, and this occurred
within 24 h. Interestingly, this competitive growth advantage was
not observed in homogeneous broth culture. These results further
reinforce the hypothesis that SCVs are particularly adapted to the
biofilm environment. The SCVs of some strains can phenotypi-
cally switch back to the wild-type morphology under certain
environmental conditions (11). However, the molecular mecha-
nisms underlying this phenomenon are not well studied, espe-
cially at the genomic level.
Whole-genome sequencing and microarray studies also sug-
gest that SCVs adapt genetically and transcriptionally to specific
environmental stresses, e.g., antibiotic treatment or nutrient lim-
itation. In P. aeruginosa PAO1, SCVs contained mutations in the
elongation factor tufA (11) and the cyclic-di-GMP (c-di-GMP)
regulator yfiR (15). Importantly, the deletion of yfiR in strain
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PAO1 resulted in the formation of SCVs and elevated c-di-GMP
levels, which indicated a key role of cyclic-di-GMP in phenotypic
variation (15). YfiR is one of two negative regulators of YfiN, a
diguanylate cyclase originally named TpbB (16). TpbB/YfiN also
is controlled by the phosphatase TpbA, and activation of TpbB/
YfiN by inactivation of TpbA causes SCV formation (16). These
data suggest that YfiR-TbpA-TbpB/YifN pathways can be linked
to the SCV phenotype in P. aeruginosa. In addition to genetic
changes, SCVs also undergo substantial transcriptional repro-
graming. Microarray analyses have been conducted to identify
genes responsible for the pleiotropic phenotypes observed in
SCVs. In P. aeruginosa PAO1, 642 genes, representing 12% of
the entire genome, were differentially expressed in an SCV com-
pared with the WT (11). These include genes involved in antibi-
otic resistance and quorum sensing, which often contribute to the
multidrug resistance phenotype. Another study comparing the
transcriptome of P. aeruginosa 20265 with its SCV derivative in-
dicated changes in the expression levels of genes involved in mo-
tility, attachment, virulence, and iron uptake (17). Genome se-
quencing and transcriptome approaches to understanding
adaptation should provide important complements to phenotypic
studies of bacterial SCVs (18).
In this study, we examined the transcriptional and genomic
alterations associated with the SCV phenotype in the beneficial
root-colonizer P. chlororaphis 30-84. Genome analysis of a pheno-
typic revertant strain also was performed to identify genes poten-
tially involved in phenotypic switching. This work comprises a
genome-wide evolutionary analysis of a phenotypic switching
event in P. chlororaphis. Genes identified by genomic or transcrip-
tomic approaches will provide novel insights to better understand
genetic adaptations during biofilm formation.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The P. chlororaphis SCVs used
for this study were isolated from biofilm cultures of WT P. chlororaphis
30-84. Briefly, bacteria were grown overnight in LB medium and then
inoculated at a ratio of 1:150 into 15 ml 15- by 100-mm glass tubes con-
taining 1.5 ml LB. Tubes were incubated without shaking for 6 days to
induce static biofilm formation. Phenotypically identical SCVs account-
ing for 50% of the total population were consistently isolated from
independent biofilm cultures.More than a dozen SCVs from independent
biofilm cultures were isolated, and one of the SCVs was selected for this
study. Phenotypic revertants were generated by incubating the SCV strain
on swimming motility plates (LB medium; 2.5 g agar per liter distilled
water). After 3 days of incubation, cells having the wild-type morphology
(e.g., phenotypic revertants) were isolated from the edge of the swimming
circle, and one was selected for further analysis. Primers used for PCR are
listed in Table S1 in the supplemental material. LB medium or AB mini-
mal medium supplemented with 2% Casamino Acids (AB plus 2% CAA)
(Difco, BectonDickinson andCompany, Franklin Lakes, NJ) was used for
culturing P. chlororaphis as described previously (19).
PCR and sequence analysis. PCR was carried out using Taq DNA
polymerase (Invitrogen Life Technologies) at 95°C for 5 min, followed by
30 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 90 s, and then a final
elongation step of 70°C for 10min. Nucleotide and amino acid homology
searches were conducted using the blast programs at the National Center
for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov
/BLAST). The P. chlororaphis 30-84 phenazine biosynthetic operon con-
tains seven conserved biosynthetic genes phzXYFABCD (according to the
original nomenclature [19, 20]), which correspond to phzABCDEFG (ac-
cording to the P. fluorescens nomenclature). Here, we use the P. chlorora-
phis nomenclature to conform to the original literature.
Cloning yfiR, cyoE, bifA, and fusA genes from P. chlororaphis. For
yfiR, fusA, and cyoE complementation, flanking sequences of the open
reading frames (ORFs) in the P. chlororaphis WT were used to design
primers to amplify fragments of the genes and their promoter sequences.
Primer pairs yfiR-F–yfiR-R, fusA-F–fusA-R, and cyoE-F–cyoE-R were
used to amplify DNA fragments from the P. chlororaphisWT strain, con-
taining upstreamanddownstream sequences of yfiR, fusA, and cyoE genes,
respectively (see Table S1 in the supplemental material). The PCR frag-
ments were digested by restriction enzymes and cloned into the vector
pProbeGT= (pGT2) (19). The final plasmids were designated pYfiR,
pFusA, and pCyoE, and their genotypes were confirmed by sequencing.
All plasmids were introduced into the P. chlororaphis SCVby conjugation.
Transformants were selected on LB plates supplementedwith gentamicin.
The bifA gene (with its promoter) was cloned from the phenotypic rever-
tant using primers bifA-F and bifA-R (see Table S1). The resulting plas-
mid was introduced into the P. chlororaphis SCV by conjugation.
TEM.Transmission electronmicroscopy (TEM)was performed at the
Microscopy and Imaging Center at Texas A&MUniversity. Bacteria were
grown in LBmedium for 18 h. Cells from the media were applied directly
to the TEM grid for 3 min. The grid was stained with a 2% aqueous
solution of phosphotungstic acid for 1min. Samples were examined using
a Japan Electron Optics Laboratory (JEOL) 1200 transmission electron
microscope at an acceleration voltage of 100 kV. The sizes of 10 fully
developed P. chlororaphis 30-84 and SCV cells were measured and com-
pared. All of the SCVs demonstrated dark areas in the centers of the cells.
Quantification of phenazine production. Bacterial strains were
grown with aeration at 28°C in PPMD, LB, and AB minimal medium
supplemented with 2% CAA for 24 h. Phenazines were extracted and
quantified by UV-visible light spectroscopy as described previously (19).
Briefly, triplicate 10-ml cultures grown overnight at 28°C with shaking in
different media were centrifuged, and the supernatants were acidified to
approximately pH 2 with concentrated HCl. Phenazines were extracted
with an equal volume of benzene for 6 h. Following the evaporation of the
benzene under air, phenazines were resuspended in 0.5 ml 0.1 M NaOH,
and serial dilutions were quantified via measuring absorbance at 367 nm.
The absorbance for each samplewas normalized to the total absorbance of
the 10-ml culture.
Pathogen inhibition assays. To measure the ability of the WT and
SCV to inhibit the pathogen G. graminis var. graminis, overnight cultures
of WT and SCV were spotted onto triplicate LB plates plus 0.5% potato
dextrose agar. After 2 days of growth at 28°C, a 5-mm plug of G. graminis
var. graminis was placed in the center of the plates. After 4 days, zones of
inhibition, the distance between the edge of the bacterial colony and the
fungal mycelium, were measured (19). The assays were repeated three
times, and one representative experiment is presented. P. chlororaphis
30-84ZN, used as a negative control, carries a mutation in the phzB gene
and is deficient in phenazine production.
Biofilm formation assay. Biofilm formation was determined as de-
scribed previously, with slight modifications (2). Briefly, bacterial strains
were grown overnight in LB at 28°C with agitation and diluted (1:100) in
LB broth. Aliquots of 3 ml of the diluted culture were added to 15-ml
polypropylene tubes, and the tubes were incubated at 28°C without shak-
ing. After 48 h, the planktonic bacteria were carefully removed by pi-
petting, and the tubes were washed with water to remove bacteria that
were not firmly attached to the polypropylene surface. To visualize bio-
film formation, 3.5 ml of 1% (wt/vol) crystal violet (CV) was added to
each tube, and the tubes were incubated at room temperature for 5 min
before rinsing in tap water. To quantify biofilm formation, CV was dis-
solved into 4ml/l of acetone-ethanol (20:80), and the CV concentration
was determined by measuring the OD540 of a 500-l sample diluted in 1
ml of water.
Bacterial swimming motility assays. Bacterial cell suspensions were
grown overnight in LB medium. A 4-l volume of the bacterial suspen-
sion was plated onto the center of motility agar plates as previously de-
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scribed (21). Diameters were determined following incubation at 28°C for
up to 32 h. The experiments were repeated at least three times.
Antimicrobial killing assays. Bacterial strains were grown separately
overnight in LB broth without antibiotics, collected by centrifugation at
5,000  g for 10 min, and washed with 1 phosphate-buffered saline
(PBS) three times. The pellets were resuspended in 200 l of PBS, and
20-fold serial dilutions of bacterial suspensions were made in 96-well
plates. Five-l aliquots of the suspensions thenwere spotted separately on
LBplates containing kanamycin (100g/ml), piperacillin (50g/ml), and
hydrogen peroxide (3%) and incubated at room temperature for 3 days.
The survival percentage was calculated by dividing antimicrobial-treated
versus untreated colony-forming numbers. The dilution of each strain
was carried out in triplicate. The experiment was repeated at least three
times.
RNApreparation for RNA-seq and quantitative PCR (qPCR) analy-
ses. Two (SCV) or three (WT) biological replicates were started from
single colonies located on separate plates containing AB plus 2%CAA and
then transferred to 1.5ml AB plus 2%CAAbroth. All cultures were grown
at 28°C in shaking tubes to an approximate OD600 of 1.8. RNA extraction
was performed as described previously (19). rRNAwas depleted from5
g of total RNA using the RiboZero rRNA depletion kit (for Gram-neg-
ative bacteria; Epicentre Biotechnologies, Madison, WI). RNA quantifi-
cation was achieved using a GE NanoVue Plus spectrophotometer (GE
Healthcare Bio-Sciences Corp., Piscataway, NJ), and RNA quality was
monitoredwith an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA). Separate libraries of the WT and SCV were created prior to
RNA-sequencing (RNA-seq) analysis.
RNA-seq analysis. RNA-seq analysis was performed at Otogenetics,
Atlanta, GA. Briefly, cDNA was generated from the rRNA-depleted RNA
using the NEBNext mRNA sample prep kit (New England BioLabs, Ips-
wich, MA, USA). The resulting cDNA was profiled using an Agilent Bio-
analyzer, fragmented using Covaris (Covaris, Inc., Woburn, MA, USA),
and subjected to Illumina library preparation using NEBNext reagents
(NewEngland BioLabs, Ipswich,MA,USA). The quality and quantity and
the size distribution of the Illumina libraries were determined using an
Agilent Bioanalyzer 2100. The libraries then were submitted for Illumina
HiSeq2000 sequencing according to the standard operation. Paired-end
90- or 100-nucleotide (nt) reads were generated and checked for data
quality using FASTQC (Babraham Institute, Cambridge, United King-
dom).
Based on gene annotation information, reads were mapped to the
genome, resulting in a compressed binary version of the sequence align-
ment map (BAM files). To determine the transcriptional abundance for
each gene, the number of reads that mapped within each annotated cod-
ing sequence (CDS) was determined. The number of reads per kb of
transcript per million mapped reads (RPKM) was used to normalize the
raw data (21), and mean RPKM values were determined for both the
wild-type and SCV samples. A ratio of themean RPKMvalues (SCV/WT)
was computed for each gene, and comparisons were performed using
EdgeR (22). Genes were identified as being differentially expressed based
on the RPKM ratios (SCV/WT) when the P value was less than 0.05 and
the expression ratio was2.0 or0.5 (see Table S2 in the supplemental
material).
qPCR methods and analysis. qPCR was performed at the Gene Ex-
pression Service Center at Texas A&M University using a previously de-
scribedmethod (19). SYBR green reactions were performed using the ABI
7900 HT Fast system (Applied Biosystems, Foster City, CA) in 384-well
optical reaction plates. Aliquots (1 l) of cDNA (2 ng/reaction mixture)
or water (no-template control) were used as the template for qPCRs with
Fast SYBR green PCRmaster mix (Applied Biosystems) and primers (500
nM final concentration). Primer pairs katART1-katAYRT2, katBRT1-
katBRT2, pvdART1-pvdART2, fppART1-fppART2, phzBRT1-phzBRT2,
fusART1-fusART2, cyoERT1-cyoERT2, fliCRT1-fliCRT2, phzRRT1-
phzRART2, rpoDRT1-rpoDRT2, and hfqRT1-hfqRT2 were used to de-
tect the expression of katA, katB, pvdA, fppA, phzB, fusA, cyoE, fliC, phzR,
rpoD, and hfq genes, respectively (see Table S1 in the supplemental mate-
rial). qPCR amplifications were carried out at 50°C for 2 min, 95°C for 10
min, 40 cycles of 95°C for 15 s and 60°C for 1min, and a final dissociation
curve analysis step from 65°C to 95°C. Technical replicate experiments
were performed for each biological triplicate sample. Amplification spec-
ificity for each reaction was confirmed by dissociation curve analysis. De-
termined threshold cycle (CT) values then were used for further CT
analysis. The hfq and rpoD genes were used as the reference genes to
normalize samples. The fold differences in the expression of target genes
between theWT and SCVwere comparable using either hfq or rpoD as the
reference gene. A relative quantification (RQ) value was calculated for
each gene, with the control group as a reference (19, 21).
Genome sequencing and identification of genetic variations. Ge-
nome sequencing was performed using a MiSeq sequencer with 250-bp
read chemistry (Illumina). A modified TruSeq DNA Sample Prep v2 and
MiSeq sequencing protocol was used during the sequencing process (23).
Briefly, genomic DNA from the WT, SCV, and the phenotypic revertant
was isolated fromovernight cultures using theDNeasyMiniprep kit (Qia-
gen, Hilden, Germany). The genomic library was constructed using 1 g
of genomic DNA fragmented by a Covaris E210 instrument. The samples
then were run on a gel and size selected for a range of 400 to 500 bp to
accommodate the longer read length capability of the MiSeq sequencer.
The size-selected library underwent 10 cycles of PCR. The libraries were
quantified using the Qubit double-stranded DNA high-sensitivity assay
(Invitrogen, Carlsbad, CA, USA). The sequencing program was set up to
generate 2-by-250 base-paired reads.
MiSeq sequencing generated a total of 6,954,294 reads. The reads were
mapped to the reference genome of P. chlororaphis 30-84 (NCBI accession
number NZ_CM001559). The reads were trimmed using the Perl script
illumina_fastq_QC.pl (https://github.com/chienchi/IFQC)with a quality
threshold of 5 to remove sequences of low read quality or sequences with
adapters. The program also filtered reads with more than two continuous
ambiguous bases and low-complexity reads (mono/dinucleotide repeats).
The Burrows-Wheeler Aligner software (default parameters; version
0.6.2-r126-tpx) (24) was used tomap Illumina reads to the P. chlororaphis
30-84 genome. This software includes a gapped alignment algorithm,
which improves the detection of indel read pairs (90.67% of the original
reads). Readsweremapped to unique locations, resulting in amedian read
depth (genome coverage) of 46. Single-nucleotide polymorphisms
(SNPs) and indels were detected with SAMtools software (version 0.1.19)
using its built-in function “mpileup” and the “bcftools view” and “vcfutil-
s.pl varFilter” commands in a pipeline to call the SNPs (24). Custom
scripts developed by the Los Alamos National Laboratory were used to
filter the variants based on a minimum overall quality of 20 reads and
variant location in the repeats. The resulting SNPs/indels and zero-cov-
ered regions of the reference genome were compared with GenBank an-
notation to report affected genes.
GEO accession number. The complete data set from this study has
been deposited in the NCBI Gene Expression Omnibus (GEO) under
accession no. GSE51293.
RESULTS
Phenotypic characterization of a P. chlororaphis SCV. (i) Cell
morphology and growth. The colony morphologies of the WT
and SCV on LB agar plates are shown in Fig. 1A. Isolated colonies
formed by WT P. chlororaphis after 3 days of incubation at 28°C
are round (4.0 1.1mm in size), with smooth, regularmargins.
In contrast, SCV colonies appear rugged and small (0.6  0.5
mm in diameter). Morphological differences were reflected at the
single-cell level (Fig. 1B). Typically present in the center of SCV
cells was a dark area not found in WT cells grown under these
environmental conditions, possibly due to the condensation of
the nucleoid. Reduced metabolic activity and slower growth are
characteristic of SCVs of many bacterial species (18). Consistent
Wang et al.
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with this, the SCVs of P. chlororaphis 30-84 grown in liquid LB
entered the exponential phase later than the WT; thus, they dis-
played a longer lag phase (Fig. 1C).
(ii) P. chlororaphis SCV produces smaller amounts of
phenazines than the wild type. Phenazine production was quan-
tified by spectrophotometric assays for bacteria grown in ABmin-
imal medium plus 2% Casamino Acids (19). Phenazine produc-
tion by SCV (2.1  0.4 at OD367) was significantly reduced
compared to that of theWT (3.5 0.3 at OD367). The production
of phenazines is largely responsible for the ability ofP. chlororaphis
30-84 to inhibit the growth of fungal pathogens (20). The ability to
inhibit the growth of the plant pathogen G. graminis was deter-
mined using an in vitro plate inhibition assay. TheWT strain pro-
duced a fungal inhibition zone of approximately 7.5 0.9 mm at
4 days postinoculation, whereas the phenazine-defective mutant
P. chlororaphis 30-84ZN resulted in significantly low inhibition
(inhibition zone, 1.0  0.6 mm). Consistent with low levels of
phenazine production, the SCV also was diminished in its ability
to inhibit the fungal growth at 4 days postinoculation, producing
a mean inhibition zone of 3.2 0.7 mm.
(iii) P. chlororaphis SCV is sessile and highly adhesive. Pre-
vious studies demonstrated that SCVs typically are reduced in
motility but increased in surface attachment (11, 12). To deter-
mine whether P. chlororaphis SCVs are altered in attachment, the
ability of the wild type and SCV to form biofilms on a water-air
interface was evaluated using a standardized crystal violet method
(2). Analysis revealed that biofilms (attached bacterial cells)
formed by the SCVwere 7-fold greater than those of theWT strain
(Fig. 1D). These results confirm that P. chlororaphis SCV cells are
highly adhesive to solid surfaces.
Bacterial motility by the wild type and SCV was measured by
inoculating bacterial cells on a motility plate (0.25% agar) and
measuring the diameter of the circle covered by bacterial cells for
up to 32 h, as described previously (21). The SCV was almost
completely defective in motility compared with theWT (Fig. 1E).
The diameters of circles delimitingWTand SCVpopulationswere
6.7  0.2 and 2.8  0.1 cm, respectively (Fig. 1F). These results
demonstrate that the SCV of P. chlororaphis 30-84 also is impaired
in motility.
(iv) P. chlororaphis SCV has enhanced antimicrobial resis-
tance compared to the wild type. One of the most remarkable
features of SCVs is enhanced antimicrobial resistance (18). To
determine whether the P. chlororaphis SCV is more resistant
to antimicrobials, WT and SCV were tested for their sensitivity to
kanamycin, piperacillin, and hydrogen peroxide, and the survival
rates of each strain were determined. On LB plates, the growth of
wild-type P. chlororaphiswas inhibited at a kanamycin concentra-
tion of 25 g/ml or above (Fig. 2A). In contrast, the SCV grew
even at 100g/ml. The SCV also wasmore resistant to piperacillin
and hydrogen peroxide (Fig. 2B). The survival rates of the WT
were 0%, 12%, and 32% when grown with kanamycin, piperacil-
lin, and hydrogen peroxide, respectively, whereas those of SCV
were increased to 93%, 74%, and 75%, respectively. These results
indicate that the P. chlororaphis SCV ismore resistant to a range of
antimicrobials.
Global gene expression profiles in the SCV. To further define
the causes for the phenotypic differences observed between the
wild type and SCV, an RNA-seq approach was utilized to identify
genes differentially expressed. We compared the SCV to the WT
grown in ABminimal medium with 2% CAA at 18 h in late expo-
nential growth. RNA-seq data (short reads) were aligned to the
genome, and gene expression values were quantified as reads per
kilobase of coding sequence (CDS) length per million reads
(RPKM), as described previously (21). In order to identify genes
differentially expressed in SCV, mean RPKM values for the SCV
were compared with those for theWTusing EdgeR (22). A total of
1,098 genes exhibited altered expression profiles in the SCV rela-
tive to the WT strain. Among them, 727 genes were upregulated
and 371 genes were downregulated, indicating extensive tran-
scriptional reprogramming in SCV cells (see Table S2 in the sup-
plemental material).
Transcription of genes involved in specific metabolic func-
tions was reduced in the SCV compared to that of theWT. It has
been proposed that condensed chromatin contributes to the low
FIG 1 Phenotypes of SCV. (A) Comparison of colony sizes of P. chlororaphis
WTand SCV. Bacteria were grown on an LB plate for 3 days. (B) Transmission
electron microscopy analysis of cell morphology for P. chlororaphis WT and
SCV. Bacteria were grown with shaking at 200 rpm and 28°C in LBmedium to
an OD600 of 1.8. Cells were negatively stained with 1% phosphotungstic acid
(pH 7.0), and micrographs were taken at an accelerating voltage of 100 kV.
One photo of a representative cell for each strain was selected. (C) Growth
curves of P. chlororaphis WT and SCV in LB broth at 28°C. Original inocula
from stationary cultures were inoculated at a volume-to-volume ratio of
1:1,000. (D) Biofilm formation by P. chlororaphis WT and SCV. Bacterial
strains were grown overnight in LB broth at 28°C and diluted (1:100) in fresh
LB media, and aliquots of 3-ml bacterial cultures were incubated at 28°C,
without shaking, in 15-ml falcon tubes. After 48 h, liquid cultures were de-
canted, and cells in biofilms adhering to the side of the tubes were stained with
1% crystal violet (CV). The amount of CV staining was quantified at OD540,
and bars indicate standard errors (SE). Biofilm production was normalized to
an OD600 of 1 for both the WT and SCV. CK, no bacteria. (E) Motility com-
parison of P. chlororaphis WT and SCV. Bacterial strains were spotted at the
center of the motility plate (0.25% agar) and incubated at 28°C. Pictures were
taken at 24 h postinoculation. (F) Comparison of swimming distances. The
diameters of the swimming circle were measured at 8, 16, 24, and 32 h postin-
oculation. Standard error bars were smaller than the symbols. Data points
represent means  SE from nine biological replicates in three independent
experiments.
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metabolic activity observed among the SCVs of some bacteria
(25). One possibility is that condensed chromatin results in the
decreased expression of metabolic genes. Consistent with this hy-
pothesis, the expression of genes involved in primary metabolism
was lower in the SCV than in the WT strain (see Table S3 in the
supplemental material). These included genes that may be in-
volved in housekeeping functions, such as protein translation (18
genes), transcription (2 genes), energy production (16 genes), and
cell division (2 genes). These results further support the notion
that P. chlororaphis 30-84 SCVs are less metabolically active than
the WT.
SCV showeddifferential expression of genes involved in bio-
film formation.Consistent with themeasured reduction in phen-
azine production, the phenazine biosynthetic genes were down-
regulated 2- to 4-fold in the SCV (see Table S4 in the supplemental
material). In P. chlororaphis 30-84, phenazine expression is regu-
lated by a complex regulatory network, including quorum sensing
(phzI-phzR and csaI-csaR), two-component regulatory systems
(rpeA-rpeB and gacS-gacA), the phenazine-inducing protein (pip),
the sigma factor rpoS, and the noncoding RNA rsmZ (19). Inter-
estingly, the expression of these genes was not differentially
changed in the SCV relative to the WT (data not shown). These
data suggest that phenazine production is regulated by an as-yet
unknown mechanism in the SCV. Since phenazines positively
control biofilm formation, the reduction of phenazine synthesis in
the SCV should decrease the level of biofilm formation. Interest-
ingly, the SCV produced more surface-attached biofilm than the
WT. These results suggest that surface-attached biofilm in the
SCV is controlled by genes and traits in addition to phenazines.
Indeed, the expression of an 11 gene cluster annotated as a type IV
pili biosynthesis cluster was 2- to 15-fold higher in the SCV than in
the WT (see Table S4 in the supplemental material). It has been
shown that type IV pili function in P. aeruginosa twitching motil-
ity and attachment (17). It is possible that the overexpression of
these genes confers greater adherence ability in SCV. The motility
of P. chlororaphis 30-84 requires flagellar genes, and mutation in
the fliM gene completely abolished motility (21). Transcript
abundances of seven flagellar genes were lower in the SCV than in
theWT (see Table S4). These genes are annotated as encoding the
flagellar hook-associated protein (FlgK and FlgL), the flagellar
motor switch protein (FliG), the flagellar assembly protein (FliH),
the flagellum-specificATP synthase (FliI), the flagellar export pro-
tein (FliJ), and flagellin (FliC). This is in agreement with the re-
duced swimmingmotility of SCV.Moreover, it was proposed that
the reduction of flagella helps to stabilize the three-dimensional
structure of the mature biofilm (5). The enhanced ability of SCV
to form biofilms may be a consequence of the differential expres-
sion of genes involved in the production of pili and flagella (see
Table S4).
Expression of stress-related and iron uptake genes was in-
creased in the SCV. The exposure of P. chlororaphis SCV to anti-
microbials on solid agar, including hydrogen peroxide, revealed a
higher level of resistance to oxidative stress than that in the WT
strain (Fig. 2B). This indicates that this clonal small-colony vari-
ant is especially adapted to oxidative stress. Supporting these re-
sults, the key oxidative stress regulator oxyR was found to be sig-
nificantly induced in the SCV (see Table S5 in the supplemental
material). This LysR-type redox sensor binds DNA as a dimer
while responding to elevated cellular levels of reactive oxygen spe-
cies (ROS) (26). In P. aeruginosa, activated OxyR (encoded by
PA5344) stimulates the expression of katA, katB, ahpB, and ah-
pCF, which encode catalases and alkyl-hydroxy peroxidases (27).
Besides having a crucial role in upregulating oxidative stress de-
fense, OxyR contributes to P. aeruginosa iron acquisition by acti-
vating genes involved in pyoverdine biosynthesis and utilization
(28). In agreement with these results, five oxidative stress scaveng-
ing genes, including katABG and ahpCF, and 18 iron uptake genes,
including pvd genes for pyoverdine synthesis and tonB and exb
genes for pyoverdine utilization, were highly expressed in the P.
chlororaphis SCV (see Table S5).
Validation of RNA-seq.To validate the expression profiles ob-
tained by RNA-seq, quantitative reverse transcription-PCR (qRT-
PCR) was performed on 9 selected genes; these included genes
encoding components of the quorum-sensing systems; proteins
involved in heme, flagellar, phenazine, and pyoverdine synthesis;
and enzymes previously shown to detoxify reactive oxygen spe-
cies. The data (e.g., fold differences in mutant versus WT tran-
script abundances) from the qRT-PCR analysis were comparable
to those obtained by the RNA-seq analysis for all selected genes
(see Fig. S1 and Table S2 to S5 in the supplemental material),
validating the RNA-seq data.
Genome variation betweenWT and SCV and complementa-
tion analysis. To identify genetic differences between theWT and
SCV, the genomes of both strains were sequenced. Notably, a mu-
tation was mapped to a gene annotated as yfiR and harboring an
in-frame 33-bp deletion in its coding sequence (Table 1). This
mutation causes a deletion of 11 amino acids (VLVQRLLADNP)
between residues 94 and 104 of YfiR. This periplasmic protein is a
negative regulator of cyclic-di-GMP synthesis (13). In P. aerugi-
nosa, mutation of yfiR results in the accumulation of cyclic-di-
GMP and the formation of SCV.
To determinewhether the specific geneticmutation in yfiRwas
responsible for the observed phenotypic changes, we expressed
FIG 2 Antimicrobial killing assays. (A) Kanamycin sensitivity test on LB
plates. Bacteria were grownwith shaking at 28°C in LBmedium to anOD600 of
0.5 and then diluted 1/20 a total of 5 times. Aliquots (10 l) of different
bacterial cells were spotted on LB plates with/without 100 g/ml kanamycin.
Pictures were taken at 3 days postinoculation. (B) Survival rates in response to
different antimicrobials. Serially diluted WT and SCV were plated on LB agar
plates containing 100 g/ml kanamycin (Km), 50 g/ml piperacillin (Pin),
and 3% hydrogen peroxide (H2O2). Surviving bacterial cells were counted
after 3 days of incubation. Data points represent the means from three biolog-
ical replicates standard errors.
Wang et al.
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the wild-type yfiR gene in the SCV. The presence of the wild-type
yfiR gene complemented most SCV phenotypes, including motil-
ity, colony size, cell morphology, growth, and biofilm formation
(Fig. 3A to E). Phenazine produced by the yfiR complemented
strain was similar to that produced by the WT (e.g., 3.4  0.3 at
OD367). These data indicate that YfiR is responsible for most ob-
served phenotypes in the SCV. Interestingly, the SCV comple-
mented by WT YfiR remained antibiotic resistant, indicating that
the antibiotic resistance of the SCV is controlled by other factors.
In addition to the mutation in yfiR, other short insertions,
deletions, and SNPs were detected (Table 1). In line with the tran-
scriptional analysis, changes were identified in genes annotated as
fusA (elongation factor G) and cyoE (protoheme farnesyltrans-
ferase) (Table 1). The fusA gene contains an SNPwhich substitutes
an alanine (A) for valine (V) at residue 664. In Salmonella enterica
serovar Typhimurium, point mutations in the fusA gene can lead
to an increased resistance to kanamycin and fusidic acid (29).
CyoE is involved in the production of heme, a cofactor involved in
oxygen-dependent electron chain reaction (30). A previous report
showed that the disruption of the electron transport chain re-
duced the membrane potential and the ability to take up antibiot-
ics, e.g., leading to increased resistance to aminoglycosides (31).
An in-frame 12-bp insertion potentially resulted in the addition of
4 amino acids (ILLY) at positions 208 to 211 in CyoE (Table 1). It
is possible that changes in the residues in the 6th transmembrane
domain by the addition of 4 hydrophobic amino acids alters the
conformation of CyoE sufficiently to affect transport (see Fig. S2
and S3 in the supplemental material).
To test the role of FusA in the antibiotic resistance of the SCV,
the altered fusA from the SCVwas introduced into theWT, result-
ing in increased kanamycin resistance, but not to the level of re-
sistance seen in the SCV (Fig. 3F). However, failure of the altered
fusA to induce the SCV level of kanamycin resistance when ex-
pressed in trans in the wild-type background is not unexpected,
given the existence of a wild-type copy of fusA in the genome. To
TABLE 1 List of genetic changes in P. chlororaphis SCV and phenotypic revertant
Gene identifier Gene Protein description Type Protein change Position on protein
Presence ina:
SCV Revertant
Pchl3084_0735 yfiR Periplasmic protein 33-bp deletion In-frame deletion 94–104  
Pchl3084_4816 cyoE Protoheme farnesyltransferase 12-bp insertion In-frame insertion 208–211  
Pchl3084_0164 Glycosyl hydrolase SNP A to T 1188  
A to T 1190
N to D 1197
T to A 1208
N to D 1214
Pchl3084_5323 fusA Elongation factor G SNP A to V 664  
Pchl3084_1083 xerD Tyrosine recombinase 2-bp insertion Frame shift 276  
Pchl3084_0637 Precorrin methyltransferase SNP R to G 126  
Pchl3084_0840 Hypothetical protein SNP N to S 220  
Pchl3084_1162 cdsA Phosphatidate cytidylyltransferase SNP F to L 214  
G to A 219
Pchl3084_1218 Phage tail protein SNP F to Y 320  
A to D 346
Pchl3084_3246 Transcriptional regulator SNP L to M 318  
T to P 319
V to I 316
H to R 208
Pchl3084_4624 bifA Phosphodiesterase SNP V to L 598  
a, presence of mutations;, absence of mutations.
FIG 3 Phenotypes of the yfiR and fusA complemented strain. (A) Comparison
of colony sizes of P. chlororaphisWT, SCV, and the yfiR complemented strain.
Bacteria were grown on LB plates for 3 days. (B) Transmission electron mi-
croscopy analysis of cell morphology for P. chlororaphisWT, SCV, and the yfiR
complemented strain. (C) Growth curves of P. chlororaphisWT, SCV, and the
yfiR complemented strain in LB broth at 28°C. Original inocula from station-
ary cultures were inoculated at a volume-to-volume ratio of 1:1,000. (D) Bio-
film formation by P. chlororaphisWT, SCV, and the yfiR complemented strain.
The amount of CV staining was quantified at OD540, and bars indicate SE.
Biofilm production was normalized to an OD600 of 1 for different strains. (E)
Motility comparison of P. chlororaphisWT, SCV, and SCVharboringWT yfiR.
Bacterial strains were spotted at the center of the motility plate (0.25% agar)
and incubated at 28°C. Diameters were measured at 32 h postinoculation. (F)
Survival rates in response to kanamycin. Similar amounts (OD600 	 0.1) of
different bacterial strains were inoculated on LB plates containing 10 g/ml
kanamycin. The picture was taken 3 days after inoculation. All data points
represent means  SE from nine biological replicates in three independent
experiments.
Evolution of P. chlororaphis
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determine if the mutation of cyoE contributed to kanamycin re-
sistance, the WT cyoE gene was introduced in trans into the SCV.
However, the SCV harboring the WT cyoE was not decreased in
kanamycin resistance (data not shown). These results suggest that
cyoEmutation does not contribute to the kanamycin resistance in
the SCV.
A prominent genetic difference between the WT and the SCV
was the deletion in the SCV of an 70-kb genomic island. This
genetic element is the largest one among the three putativemobile
genomic islands in P. chlororaphis 30-84 (32). The genomic island
also is unique to P. chlororaphis 30-84 and harbors intact phage
integrases (32), which may explain its mobile nature. Interest-
ingly, the genomic island is located at a transition of GC skew and
has a low GC content compared to the average value of the whole
genome (see Fig. S4 in the supplemental material). This deletion
also is supported by the RNA-seq data, since no reads were de-
tected for the 40 genes (Pchl30-84_2928 to Pchl30-84_2967)
within this region (see Table S2). Among these genes, 22 are an-
notated as hypothetical proteins (see Table S6). Twelve genes en-
codeDNAmodification/interacting proteins, such as transposases
(3 genes), integrases (4 genes), helicase (1 gene), nucleases (2
genes), and transcriptional factors (2 genes). Two genes, tcdA1
and tcdC1, encode functionally uncharacterized insecticidal toxin
complex (Tc) proteins.We also designed primers for genes within
and flanking this genomic island and confirmed the loss of this
genomic island in this SCV (data not shown; also see Table S1).
How or whether this genomic island contributes to the forma-
tion of SCV phenotypes remains unclear. Interestingly, loss of the
genomic island as determined by PCRwas not observed in all SCV
isolates obtained from the biofilm (data not shown), suggesting
that this loss is not required for the expression of the morpholog-
ical SCV phenotypes (e.g., small colonies). Furthermore, as dis-
cussed above, mutations in yifR play a major role in controlling
SCV colony size, growth, motility, and biofilm formation in this
study. The phenotypes conferred by the loss of this genetic island
in the SCV still are not known.
Phenotypic switching and associated genetic alterations.
During prolonged incubation of the SCV on swimming motility
plates, phenotypic revertants morphologically similar to the WT
were isolated from the edge of the swimming circle, and one was
further characterized. Analysis revealed that the phenotypic rever-
tant was similar to the WT in colony size, growth rate, biofilm
formation, and motility (Fig. 4A to E). However, the phenotypic
revertant remained as resistant to kanamycin as the SCV (Fig. 4F).
These results suggest that the SCV undergoes partial phenotypic
switching, but that the antibiotic resistance phenotype of the SCV
can be retained by the revertant. The genome was sequenced to
identify the genetic changes that occurred in the phenotypic re-
vertant. As expected, the phenotypic revertant still lacked the
70-kb region, but interestingly it also retained all of the other
mutations identified in the SCV (Table 1; also see Fig. S4 in the
supplemental material). These results suggest that the phenotypic
switching is not due simply to genetic reversion of defects in the
SCV genes. Instead, seven other genes containing mutations were
identified, demonstrating that compensatory mutation(s) occur-
ring elsewhere in the genome were responsible for phenotypic
switching (Table 1). These mutations occurred in bifA (phos-
phodiesterase), xerD (tyrosine recombinase), Pchl3084_0637
(precorrin methyltransferase), Pchl3084_0840 (hypothetical pro-
tein), cdsA (phosphatidate cytidylyltransferase), Pchl3084_1218
(phage tail protein), and Pchl3084_3246 (transcriptional regula-
tor). Becausemutations in bifAwere shown to cause severe defects
in swarming motility and a hyperbiofilm phenotype in P. aerugi-
nosa (33), we investigated the role of BifA in the SCV phenotypic
reversion of P. chlororaphis. However, complementation of the
SCV with the bifA gene from the phenotypic revertant resulted in
no measurable changes in phenotypes (data not shown). Future
experiments are needed to characterize the contribution of the
other genes to the revertant phenotype.
DISCUSSION
In this study, an SCV obtained from a biofilm culture has been
systematically investigated at the phenotypic, transcriptional, and
genomic levels. Changes in growth, motility, and phenazine pro-
duction, as well as biofilm formation and antimicrobial resistance,
correlate well with changes in gene expression as analyzed by ge-
nome-wide RNA-seq analysis. In addition, spontaneous muta-
tions in yfiR and fusA are linked to key phenotypes in the SCV.
This confirms that the changes in the SCV across these diverse
cellular processes are controlled by genetic variations. Further-
more, phenotypic revertants were recovered that were similar to
theWT in colony size, growth rate, biofilm formation, andmotil-
ity but remained as resistant to kanamycin as the SCV. These
FIG 4 Phenotypes of the phenotypic revertant strain. (A) Comparison of
colony sizes of P. chlororaphis WT, SCV, and phenotypic revertant strains.
Bacteria were grown on an LB plate for 3 days. (B) Colony sizes on LB plates.
Different strainswere grown at 28°Con anLB agar plate for 3 days. (C)Growth
curves of P. chlororaphis WT, SCV, and phenotypic revertant strains in LB
broth at 28°C. Original inocula from stationary-phase cultures were inocu-
lated at a volume-to-volume ratio of 1:1,000. (D) Biofilm formation by P.
chlororaphis WT, SCV, and phenotypic revertant strains. Biofilm production
was normalized to an OD600 of 1 for different strains. (E)Motility comparison
of P. chlororaphis WT, SCV, and the phenotypic revertant. Bacterial strains
were spotted at the center of the motility plate (0.25% agar) and incubated at
28°C. Diameters were measured at 32 h postinoculation. (F) Survival rates in
response to kanamycin. All data points represent means SE from nine bio-
logical replicates in three independent experiments.
Wang et al.
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results suggest that the SCV undergoes partial phenotypic switch-
ing, but that the antibiotic resistance phenotype of the SCV can be
retained by the revertant. This observation has important clinical
implications, since phenotypic switching provides a mechanism
for the development of antibiotic resistance. These results also
highlight the strength of coupled phenotypic and transcriptomic
analyses, in combination with whole-genome sequencing, as an
approach to unravel complex bacterial adaptations.
A role for cyclic-di-GMP in phenotypic variation has been sug-
gested previously. InP. aeruginosaPAO1, an SCVhaving the char-
acteristic phenotypes (small-colony morphology, decreased mo-
tility, and enhanced attachment) emerged as a result of
transposon mutagenesis of the cyclic-di-GMP regulator yfiR. A
model for howYfiR repression of YfiN (TpbB) regulates cyclic-di-
GMP levels and SCV formation was proposed (15). Cyclic-di-
GMP anabolism is driven by the catalytic activity of GGDEF mo-
tif-containing diguanylate cyclases (DGC), such as YifN, which
generate c-di-GMP from two molecules of guanosine-5=-triphos-
phate (GTP). C-di-GMP catabolism is driven by the catalytic ac-
tivity of EAL motif-containing phosphodiesterases (PDE), which
break down c-di-GMP into 5=-phosphoguanylyl-(3=-5=)-guanos-
ine (pGpG) (34). YfiR is a periplasmic protein that serves as a
repressor of YfiN (TpbB). Mechanistically it is believed that YfiR
binds to YfiN (TpbB) and halts the conversion of the two GTP
molecules to c-di-GMP by YfiN (TpbB). Consistent with this
model, deletion of yfiR in P. aeruginosa resulted in increased c-di-
GMP levels, linking changes in the c-di-GMP pool to characteris-
tic SCV phenotypes (15). It is hypothesized that c-di-GMP levels
control phenotypic changes by interacting with proteins or ribo-
switches that control gene expression or the activity of enzymes
and complex cellular structures (34). It is further speculated that
these changes are involved in the transition from motile to non-
motile lifestyles (34). In P. chlororaphis 30-84, complementation
of the SCV with a wild-type copy of yfiR restored the wild-type
colony morphology, motility, biofilm formation capability, and
growth rate. Although the accumulation of c-di-GMP was not
measured, our results are consistent with the P. aeruginosamodel
and suggest that mutation of yfiR in the SCV lessened the affinity
of yfiR to bind to and repress the catalytic activity of YfiN. This
would result in the accumulation of c-di-GMP and, ultimately,
the SCV phenotype.
Retention of the SCV mutations in yfiR in the phenotypic re-
vertant suggested that the revertant phenotype was derived from
secondary mutations. We hypothesized that these mutations ei-
ther affect c-di-GMP levels (e.g., reduce pools to be more similar
to wild-type levels) or directly affect phenotypes controlled by
c-di-GMP levels, e.g., type IV pili or extracellular polymeric sub-
stance production (13, 15, 35). The phenotypic revertant charac-
terized in this study had a point mutation in the gene encoding a
well-studied PDE, bifA (33, 36). Hypothetically, a mutation that
increases the catalytic activity of the PDE bifA could counteract
the effects of the yfiR mutation by breaking down the c-di-GMP
that accumulated in the cells as a result of the unregulated catalytic
activity of yfiN (tpbB). Interestingly, the introduction of the rever-
tant copy of bifA into the SCV did not result in any noticeable
phenotypic changes. These results suggest that the mutation to
bifA observed in the phenotypic revertant was not responsible for
the emergence of the revertant phenotype, and that another mu-
tation(s) observed in the revertant is responsible for the pheno-
typic change. Future work will include complementation assays to
determine the genetic change responsible for the phenotypic re-
version.
The SCV characterized in this study was highly resistant to the
aminoglycoside kanamycin. The molecular mechanisms of bacte-
rial uptake and resistance to aminoglycosides have been studied
extensively. Antibiotic resistance to aminoglycosides typically
arises from alterations to the target of aminoglycosidic antibiotic
action, the protein synthesis machinery (37, 38). However, the
inability of the highly polar aminoglycosidic molecules to cross
the outer and inner membranes or the presence of enzymes to
inactivate the aminoglycoside also may contribute to resistance
(37, 38). To understand the antibiotic resistance phenotype of the
SCV and the revertant, we focused on genes that may influence
these antibiotic resistance mechanisms. Kanamycin inhibits pro-
tein synthesis by binding the 30S ribosome and inhibiting the
translocation of the ribosome and proofreading capability of the
protein synthesis machinery (37). Previously, mutations to elon-
gation factor G (EF-G) encoded by the gene fusA led to slight
increases in resistance to kanamycin (29). Elongation factor G is
involved in the translocation of the ribosome during protein syn-
thesis, andmutations to EF-Gmay alter the capability of kanamy-
cin to bind the ribosome to prevent translocation. In P. chlorora-
phis 30-84, the introduction of the altered fusA from the SCV in
trans into the wild type resulted in an increase in resistance to
kanamycin. The possibility that changes in antibiotic uptake by
the SCV also contributed to antibiotic resistance was suggested by
the finding that several genes involved in electron transport were
expressed to amuch lesser extent in the SCV than in the wild type.
The uptake of aminoglycosides into the bacterial cell is dependent
on the membrane potential generated by the activity of the elec-
tron transport chain (37, 39–42). We hypothesize that the com-
pound effects of decreased expression of electron transport genes
will lower the efficiency of the electron transport system, thereby
diminishing the membrane potential and the amount of kanamy-
cin taken up by the cell, as has been reported previously (18, 41,
42). The results of this study suggest that antimicrobial resistance
in the SCV, the revertant, and the SCV complemented with wild-
type yfiR is a complex phenotype regulated in part by FusA but
likely is the result of a combination of mechanisms.
In the rhizosphere, P. chlororaphis must deal with antimicro-
bials released by plants and microbes, including ROS. Moreover,
P. chlororaphis must compete with the surrounding microbial
communities for nutrients such as iron. The expression of genes
involved in ROS detoxification and iron uptake are highly up-
regulated in the SCV. These data suggest that the SCV are es-
pecially adapted to oxidative stress and low iron conditions in
the rhizosphere. The increased adherence ability of SCV may
enhance its physical association with plant roots or fungal hy-
phae to better acquire nutrients and live in plant-associated
biofilm communities. The prevalence of SCV of P. chlororaphis
30-84 and other pseudomonads in both laboratory and natural
environments suggests that there is some benefit to the SCV phe-
notype and some level of selection to maintain this phenotypic
variation within the species. Further characterization of genes
identified through RNA-seq analysis will provide a more detailed
understanding of the genetics of phenotypic switching and the
contribution of this mechanism to adaptation of this biological
control bacterium.
Evolution of P. chlororaphis
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